Coverage
-
April 10, 2018
Par Pharmaceutical Inc. shouldn't have to post a $102 million bond in its suit accusing QuVa Pharma Inc. of stealing trade secrets, as the amount is "egregiously excessive" and QuVa hasn't backed up its number with evidence, Par told a New Jersey federal court Monday.
2 other articles on this case.
View all »